Acute Cholecystitis in a High-Risk Surgical Patient: Timing of Cholecystectomy vs. Drainage
A 72-year-old woman with morbid obesity (BMI 42), type 2 diabetes (HbA1c 9.2%), and severe COPD (FEV1 45% predicted) presents with right upper quadrant pain, fever 38.9°C, and leukocytosis (18,000/µL). Ultrasound shows a distended gallbladder with wall thickening (5 mm), pericholecystic fluid, and a stone in the neck. She has been hospitalized for 48 hours with intravenous antibiotics and is clinically improving but still has pain. The surgical team is debating early versus delayed cholecystectomy versus percutaneous cholecystostomy. The anesthesiologist estimates a high perioperative risk (ASA class IV). The patient is anxious about surgery and asks about non-surgical options.
1. What is the optimal management strategy for this patient's acute cholecystitis? Discuss the evidence for early vs. delayed surgery and the role of percutaneous drainage.
Read the worked answer
For acute cholecystitis, early laparoscopic cholecystectomy (within 72 hours of symptom onset, up to 7 days) is preferred for fit patients, as it shortens hospital stay and reduces complications compared to delayed surgery. However, this patient is high-risk (ASA IV, severe COPD, poorly controlled diabetes). If she is improving with antibiotics, a delayed approach may be safer, but the risk of recurrent cholecystitis while waiting is significant. Percutaneous cholecystostomy is indicated for patients who are poor surgical candidates or fail to improve within 24–48 hours of antibiotics. It serves as a temporizing measure. In this case, since she is improving but still symptomatic and high-risk, percutaneous drainage could be considered if she deteriorates or fails to improve. However, if she remains stable, conservative management with antibiotics and delayed cholecystectomy after optimization (if possible) might be reasonable. The decision should be individualized; a multidisciplinary approach is key. Non-surgical options include antibiotics alone (high recurrence rate) or cholecystostomy. The patient should be informed of the risks and benefits.
2. If percutaneous cholecystostomy is performed, what are the subsequent management steps and potential complications? How long should the drain stay in place?
Read the worked answer
After percutaneous cholecystostomy, the drain is left in place until the patient's clinical condition improves and the tract matures (usually at least 2 weeks). A tube check (cholangiogram) can be performed to confirm position and rule out obstruction. The drain may be removed if the patient is asymptomatic and there is no evidence of persistent infection, but some advocate leaving it until definitive surgery. Complications include bleeding, bile leak, catheter dislodgement, infection, and injury to adjacent organs. If the patient becomes a candidate for surgery, a delayed cholecystectomy is recommended (usually after 6–8 weeks) to prevent recurrence. If surgery remains contraindicated, the drain may be left indefinitely or exchanged. Antibiotics should be continued until clinical improvement. The patient should be monitored for signs of sepsis or recurrent symptoms.